A Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection
Status:
Unknown status
Trial end date:
2019-10-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess efficacy of a new 14-day sequential therapy for the
rescue treatment of refractory Helicobacter pylori infection, and whether it is safe while
maintaining an ideal eradication rates. The researchers also want to testify whether a
double-dose rabeprazole has equal efficacy to double-dose esomeprazole to provide sufficient
acid inhibition.